Ronald G. Sherrill

837 citations

19 papers · 629 indexed · h-index 13

Co-authors: Rudi Pauwels Michael J. Kukla Henry J. Breslin Elizabeth E. Sugg John C. Amedio Douglass F. Taber Andrew Spaltenstein Paul A. J. Janssen
Topics: HIV/AIDS drug development and treatment (8 papers)Chemical Synthesis and Analysis (4 papers)Synthesis and pharmacology of benzodiazepine derivatives (4 papers)
Cited by: Virology Organic Chemistry Infectious Diseases
Journals: Journal of Medicinal Chemistry The Journal of Organic Chemistry Tetrahedron Letters
Partner nations: United States Germany

In The Last Decade

Ronald G. Sherrill

19 papers receiving 606 citations

Peers

Countries citing papers authored by Ronald G. Sherrill

Since Specialization

Citations

This map shows the geographic impact of Ronald G. Sherrill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald G. Sherrill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald G. Sherrill more than expected).

Fields of papers citing papers by Ronald G. Sherrill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald G. Sherrill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald G. Sherrill. The network helps show where Ronald G. Sherrill may publish in the future.

Co-authorship network of co-authors of Ronald G. Sherrill

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald G. Sherrill. A scholar is included among the top collaborators of Ronald G. Sherrill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald G. Sherrill. Ronald G. Sherrill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Substituted tetrahydro-β-carbolines as potential agents for the treatment of human papillomavirus infection 2009 ·Bioorganic & Medicinal Chemistry Letters ·John F. Miller,Elizabeth M. Turner,Ronald G. Sherrill,Kristjan S. Gudmundsson,Andrew Spaltenstein,Phiroze Sethna,Kevin Brown,Richard J. Harvey,Karen R. Romines,Pamela L. Golden	30
2	The first synthesis of 1,5-diazacyclooctan-2-one and differentially protected 1,5-diazacyclooctanes 2007 ·Tetrahedron Letters ·Ronald G. Sherrill	8
3	Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385 2006 ·Bioorganic & Medicinal Chemistry Letters ·John F. Miller,C. Webster Andrews,(unknown),Eric S. Furfine,Michael Hale,Mary H. Hanlon,Richard Hazen,István Káldor,Ed W. McLean,David J. Reynolds,(unknown),Andrew Spaltenstein,Roger D. Tung,Elizabeth M. Turner,Robert X. Xu,Ronald G. Sherrill	70
4	Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles 2005 ·Bioorganic & Medicinal Chemistry Letters ·John F. Miller,(unknown),Eric S. Furfine,Richard Hazen,István Káldor,David J. Reynolds,Ronald G. Sherrill,Andrew Spaltenstein	15
5	Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·Ronald G. Sherrill,Eric S. Furfine,Richard Hazen,John F. Miller,David J. Reynolds,(unknown),Andrew Spaltenstein,Pat Wheelan,Lois L. Wright	8
6	Optimization of pyrrolidinone based HIV protease inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Ronald G. Sherrill,C. Webster Andrews,(unknown),Ronda G. Davis‐Ward,Eric S. Furfine,Richard Hazen,(unknown),Andrew Spaltenstein,Lois L. Wright	10
7	Regulation of TNF-α secretion by a specific melanocortin-1 receptor peptide agonist 2003 ·Peptides ·Diane M. Ignar,John L. Andrews,Marilyn Jansen,(unknown),(unknown),Peiyuan Lin,Ronald G. Sherrill,Jerzy R. Szewczyk,James G. Conway	24
8	1,4-Benzodiazepine Peripheral Cholecystokinin (CCK-A) Receptor Agonists 2001 ·Bioorganic & Medicinal Chemistry Letters ·Ronald G. Sherrill,Judd Berman,(unknown),Dallas K. Croom,Milana Dezube,Gregory N. Ervin,Mary K. Grizzle,Michael K. James,Michael F. Johnson,Kennedy L. Queen,Thomas J. Rimele,Frank VanMiddlesworth,Elizabeth E. Sugg	22
9	Optimization of 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists 1997 ·Journal of Medicinal Chemistry ·Brad R. Henke,Christopher Aquino,Larry S. Birkemo,Dallas K. Croom,R. W. Dougherty,Gregory N. Ervin,Mary K. Grizzle,Gavin C. Hirst,Michael K. James,Michael F. Johnson,Kennedy L. Queen,Ronald G. Sherrill,Elizabeth E. Sugg,Edward M. Suh,(unknown),Rayomand J. Unwalla,(unknown),Timothy M. Willson	63
10	Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity (II): Optimization of the C3 Amino Substituent 1996 ·Journal of Medicinal Chemistry ·Gavin C. Hirst,Christopher Aquino,(unknown),Dallas K. Croom,Milana Dezube,R. W. Dougherty,Gregory N. Ervin,Mary K. Grizzle,Brad R. Henke,Michael K. James,Michael F. Johnson,(unknown),Kennedy L. Queen,Ronald G. Sherrill,Jerzy Szewczyk,Timothy M. Willson,Elizabeth E. Sugg	31
11	An Improved Synthesis and Resolution of 3-Amino-1,3-dihydro-5-phenyl-2H- 1,4-benzodiazepin-2-ones 1995 ·The Journal of Organic Chemistry ·Ronald G. Sherrill,Elizabeth E. Sugg	22
12	A reinvestigation of the D-homoannular rearrangement and subsequent degradation pathways of (11β,16α)-9-Fluoro-11,15,17,21-tetrahydroxypregna-1,4-diene-3,20-dione (triamcinolone) 1994 ·Steroids ·Edward J. Delaney,Ronald G. Sherrill,Venkatapuram A. Palaniswamy,Thomas C. Sedergran,Sven Taylor	5
13	Synthesis and in vitro evaluation of 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indoles: high-affinity ligands for the N,N'-di-o-tolylguanidine-labeled .sigma. binding site 1993 ·Journal of Medicinal Chemistry ·Richard E. Mewshaw,Ronald G. Sherrill,Rose Mathew,Carl Kaiser,Michael Bailey,E. William Karbon	11
14	Bridged .gamma.-carbolines and derivatives possessing selective and combined affinity for 5-HT2 and D2 receptors 1993 ·Journal of Medicinal Chemistry ·Richard E. Mewshaw,(unknown),Rose Mathew,Carl Kaiser,Ronald G. Sherrill,(unknown),Carol W. Tiffany,E. William Karbon,Michael Bailey	15
15	(Aminoalkoxy)chromones. Selective .sigma. receptor ligands 1992 ·Journal of Medicinal Chemistry ·(unknown),Kenneth J. Natalie,(unknown),Zhijian Lu,(unknown),Ronald G. Sherrill,David Meloni,Raymond J. Patch,(unknown)	23
16	Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives 1991 ·Journal of Medicinal Chemistry ·Michael J. Kukla,Henry J. Breslin,Rudi Pauwels,(unknown),(unknown),Malcolm K. Scott,Ronald G. Sherrill,(unknown),(unknown)	79
17	Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives. 2 1991 ·Journal of Medicinal Chemistry ·Michael J. Kukla,Henry J. Breslin,Craig J. Diamond,(unknown),Chih Y. Ho,Milton Edson Miranda,James D. Rodgers,Ronald G. Sherrill,Erik De Clercq,Rudi Pauwels,Koen Andries,Luc Moëns,M. Janssen,Paul A. J. Janssen	146
18	Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo benzodiazepin-2(1H)-one (TIBO) derivatives 1991 ·Michael J. Kukla,Henry J. Breslin,Rudi Pauwels,(unknown),(unknown),(unknown),Ronald G. Sherrill,(unknown),(unknown),(unknown),M. Janssen,(unknown),Paul A. J. Janssen	3
19	Palladium-mediated diazo insertions: preparation of 3-alkyl-2-carbomethoxycyclopetenones 1986 ·The Journal of Organic Chemistry ·Douglass F. Taber,John C. Amedio,Ronald G. Sherrill	44

About Ronald G. Sherrill

Ronald G. Sherrill is a scholar working on Virology, Infectious Diseases and Pharmaceutical Science, having authored 19 papers that have together received 629 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Chemical Synthesis and Analysis (4 papers) and Synthesis and pharmacology of benzodiazepine derivatives (4 papers). The work is most often cited by research in Virology (133 citations), Organic Chemistry (343 citations) and Infectious Diseases (196 citations). Ronald G. Sherrill has collaborated with scholars based in United States and Germany. Frequent co-authors include Rudi Pauwels, Michael J. Kukla, Henry J. Breslin, Elizabeth E. Sugg, John C. Amedio, Douglass F. Taber, Andrew Spaltenstein, Paul A. J. Janssen, M. Janssen and Chih Y. Ho. Their work appears in journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact